🇺🇸 FDA
Patent

US 7279476

Pyrazole-derived kinase inhibitors and uses thereof

granted A61PA61P1/16A61P17/06

Quick answer

US patent 7279476 (Pyrazole-derived kinase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/16, A61P17/06, A61P19/00, A61P21/00